Manufacture Vaccines

Image of the Month: Solid Vaccines for Liquid Tumors

Researcher at the Wyss Institute at Harvard University have developed a biomaterial-based vaccine that reportedly eliminates the deadly blood cancer, acute myeloid leukemia

03/13/2020 | Quick Read

The acute myeloid leukemia vaccine is composed of a cryogel matrix that includes chemicals to attract and activate the body’s dendritic cells, which can initiate an immune response against the cancer cells and provide lasting immunity against recurrence of the disease.

Find out more visit: https://go.nature.com/3bJ6Dkx

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.